Cargando…

Indian Biosimilars and Vaccines at Crossroads–Replicating the Success of Pharmagenerics

Background: The global pharma sector is fast shifting from generics to biologics and biosimilars with the first approval in Europe in 2006 followed by US approval in 2015. In the form of Hepatitis B vaccine, India saw its first recombinant biologics approval in 2000. Around 20% of generic medication...

Descripción completa

Detalles Bibliográficos
Autores principales: Panda, Sunita, Singh, Puneet Kumar, Mishra, Snehasish, Mitra, Sagnik, Pattnaik, Priyabrata, Adhikary, Sanjib Das, Mohapatra, Ranjan K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9865573/
https://www.ncbi.nlm.nih.gov/pubmed/36679955
http://dx.doi.org/10.3390/vaccines11010110